Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lets hope it leads to a SP breakout as this tight range seems hard to break.
In my mind very undervalued.
GL.
My bad, miss read the RSS, via the Investor Meet Company platform on 22 November 2023 at 17.00 (GMT).
I think you've gained a day Warren. Its 5pm 22nd.
Is the presentation not today?
One more day left for the presentation.
This share is a sleeping giant for sure :)
Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that Sara Barrington, CEO, will provide a live presentation relating to the Company's recent global licensing and commercialisation agreement for its pre-transplant test (Clarava?) with Thermo Fisher Scientific (https://verici-dx-plc.flint-platform.com/regulatory-news/44270), via the Investor Meet Company platform on 22 November 2023 at 17.00 (GMT).
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet VERICI DX PLC via:
https://www.investormeetcompany.com/verici-dx-plc/register-investor
Yeah I’m not sure they’re quite done yet
Ok, a quick review of the shareholder cap table suggests the recent and ongoing seller is/was Marlborough Fund Managers and they're now done by the looks of it. They only had 90k shares left out of 1.6m from May-22 when they started selling. The only other sellers I can see are retail/private client brokers.
In this case, it looks like the overhang should now be firmly behind us and hopefully, this puts a bit more wind in the sails of the share price!
There may therefore not be a TR1 for this sale but perhaps there may be one or two for any new fund managers joining the party...
Looks about right to me, expect TR1s next week or two, not sure why they don’t get published T+2 or 3.
I’m in for a punt looks good to me
Verici Dx signs exclusive global licensing agreement with Thermo Fisher Scientific for pre-transplant prognostic testing
Key highlights:
✅Verici Dx has granted Thermo Fisher Scientific an exclusive global license to further develop an assay for pre-transplant risk assessment for early kidney rejection.
✅The agreement includes an upfront payment of $5 million, along with ongoing royalties on tests sold.
✅Thermo Fisher Scientific will also have non-exclusive access to a portion of Verici Dx's urine biorepository.
Impact:
✅The agreement is expected to accelerate the development of Verici Dx's technology and help it reach more patients.
✅The collaboration will expand Thermo Fisher Scientific's portfolio of transplant testing solutions.
✅This is a positive development for kidney transplant patients, as it could lead to earlier diagnosis and treatment of organ rejection.
Fingers crossed seller has done and we have an orderly market.
GL.
Tr1 maybe in coming weeks.
No tr1?
Finally, the big seller is out, and we should move upwards slowly but surely now. A 30p target for starters and a 50p target by the end of this year seem reasonable.
1,455,240 trade from Wednesday and £38k buy.
That would explain the drop this afters
...as mentioned below, there has been an ongoing seller for the best part of a year and it's unlikely whoever it is will suddenly change course and become a buyer. No clue who the seller is yet or how many they have left, if any. Either way, it's an opportunity for other funds to get involved and I'm sure the broker/dealing desks will be making outgoing calls following the news. Hotel Chocolat and the City Pub Group both got bid for today, doubly highlighting the ridiculously low valuations of UK micro and small caps.
It may be time to change strategy and start buying the news...
I added more today at 9.5p.
Unicorn Asset Management increased their holding by 2% at 34p in March last year. I'm guessing someone is loading up big time here and MMs are dropping the price to fill large orders.
Unicorn Asset Management Ltd. - 5.425% (9,239,660 shares)
Canaccord Genuity Wealth Ltd. - 4.247% (7,233,697 shares)
AXA Investment Managers UK Ltd. - 2.237% (3,809,580 shares)
Schroder Investment Management Ltd. - 1.294% (2,216,632 shares)
EKF Diagnostics Holdings PLC - 1.223% (2,092,797 shares)
Other institutional investors - 16.456% (28,043,383 shares)
Retail investors - 68.655% (116,076,280 shares)
Maybe no one is pumping the stock via Twitter and posting nonstop about it here. :)
Just fill your boots, this will motor very soon.
What's happened here then ?.
SELLERS IN FORCE
Without a doubt. A tremendous product and a JV with a real behemoth of the industry, what's not to like.
I don't think it's a question of will this rise further from here, it's when and by how much.
CEO is great and it's a good deal they have obtained.